British Columbia Cancer Agency- Centre for the Southern Interior
Kelowna, British Columbia V1Y 5L3
0 studies enrolling now · 18 studies all time
What they study most
Advanced Cancer, Anorexia, Bladder Cancer, Breast Cancer, Cachexia, Castration-Resistant Prostate Cancer, Colorectal Cancer, Fatigue, Lung Cancer, Lymphoma, Melanoma (Skin), Multiple Myeloma and Plasma Cell Neoplasm
Studies at this site
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
- Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer — Completed
- Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
- Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy — Completed
- Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ — Completed
- A Study of ARRY-334543 in Patients With Advanced Cancer — Completed
- A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer — Completed
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
- Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
- Combination Chemotherapy in Treating Patients With Multiple Myeloma — Completed
- Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
- Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 — Completed
- Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite — Completed
- Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy — Completed
- Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed
- Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma — Completed